We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
After months of escalating rhetoric, mounting tit-for-tat tariffs, and diplomatic gridlock, representatives from the world’s two largest economies finally sat down to talk trade. Approaching the weekend, expectations for common ground between the two rival nations were underwhelming – to say the least. China and the US had each imposed triple-digit tariffs on each other, so high that most investors on Wall Street essentially thought of them as a trade embargo.
Meanwhile, representatives from the United States, like Treasury Secretary Scott Bessent, said that the negotiation between the United States and China could take three years and that “everything is on the table,” including the potential to de-list US-traded Chinese ADRs such as e-commerce giants Alibaba and JD.com.
However, on Monday, stocks exploded to the upside, with the Nasdaq gaining more than 4% and the S&P 500 gaining ~3%, recouping all the losses (and then some) since President Trump’s April 2nd “Liberation Day.” Why are investors so happy? Both US and Chinese officials communicated the idea that more progress was made than initially anticipated and that the sides will finalize a pact as soon as possible.
Most importantly, each side is slashing tariffs on each other for the next 90 days. The US will cut tariffs on Chinese goods to 30% from 145%, and the Chinese will lower tariffs to 10% from 125%. The cooling of trade relations will provide Wall Street with something it hasn’t had in the past month: certainty. Finally, the US and China released an extremely rare joint statement.
Drug Prices Executive Order
President Donald Trump’s busy weekend did not stop with trade negotiations. Trump shared on his social media platform “Truth Social” that the United States will be instituting a “Most Favored Nation’s Policy” via executive order whereby the United States will pay the same price as the nation that pays the lowest price worldwide. The SPDR S&P Biotech ETF and big pharma giants like Merck were lower in early trading Monday.
OpenAI Aims for IPO
Chat-GPT-parent OpenAI made plans over the weekend to renegotiate its partnership with Microsoft to shift to a public benefit corporation to eventually IPO. OpenAI, which has been under the “non-proifit” umbrella since its founding, has been moving toward a for-profit structure for months, and this news formalizes it. Beyond OpenAI private shareholders, MSFT investors stand to benefit the most from an OpenAI IPO as Microsoft owns a 49% stake in the company.
The geopolitical backdrop also provided welcome news for Wall Street. Over the weekend, news broke that Ukranian President Zelensky and Russia’s Putin will meet to negotiate an end to the current conflict. Saturday. India and Pakistan agreed to a ceasefire amid a multi-day skirmish. Meanwhile, the final living Israeli hostage was released by Hamas. Finally, President Trump will make his first international trip of his second presidency when he visits the Middle East on Tuesday.
Bottom Line
An unexpected thaw in US-China trade relations is sending US equity markets soaring this morning.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Investment Ideas feature highlights: Alibaba, JD.com, SPDR S&P Biotech ETF, Merck and Microsoft
For Immediate Release
Chicago, IL – May 13, 2025 – Today, Zacks Investment Ideas feature highlights Alibaba (BABA - Free Report) , JD.com (JD - Free Report) , SPDR S&P Biotech ETF (XBI - Free Report) , Merck (MRK - Free Report) and Microsoft (MSFT - Free Report) .
Surprise Breakthrough: U.S./China Talks Spark Market Rally
After months of escalating rhetoric, mounting tit-for-tat tariffs, and diplomatic gridlock, representatives from the world’s two largest economies finally sat down to talk trade. Approaching the weekend, expectations for common ground between the two rival nations were underwhelming – to say the least. China and the US had each imposed triple-digit tariffs on each other, so high that most investors on Wall Street essentially thought of them as a trade embargo.
Meanwhile, representatives from the United States, like Treasury Secretary Scott Bessent, said that the negotiation between the United States and China could take three years and that “everything is on the table,” including the potential to de-list US-traded Chinese ADRs such as e-commerce giants Alibaba and JD.com.
However, on Monday, stocks exploded to the upside, with the Nasdaq gaining more than 4% and the S&P 500 gaining ~3%, recouping all the losses (and then some) since President Trump’s April 2nd “Liberation Day.” Why are investors so happy? Both US and Chinese officials communicated the idea that more progress was made than initially anticipated and that the sides will finalize a pact as soon as possible.
Most importantly, each side is slashing tariffs on each other for the next 90 days. The US will cut tariffs on Chinese goods to 30% from 145%, and the Chinese will lower tariffs to 10% from 125%. The cooling of trade relations will provide Wall Street with something it hasn’t had in the past month: certainty. Finally, the US and China released an extremely rare joint statement.
Drug Prices Executive Order
President Donald Trump’s busy weekend did not stop with trade negotiations. Trump shared on his social media platform “Truth Social” that the United States will be instituting a “Most Favored Nation’s Policy” via executive order whereby the United States will pay the same price as the nation that pays the lowest price worldwide. The SPDR S&P Biotech ETF and big pharma giants like Merck were lower in early trading Monday.
OpenAI Aims for IPO
Chat-GPT-parent OpenAI made plans over the weekend to renegotiate its partnership with Microsoft to shift to a public benefit corporation to eventually IPO. OpenAI, which has been under the “non-proifit” umbrella since its founding, has been moving toward a for-profit structure for months, and this news formalizes it. Beyond OpenAI private shareholders, MSFT investors stand to benefit the most from an OpenAI IPO as Microsoft owns a 49% stake in the company.
Geopolitics: Russia/Ukraine, India/Pakistan, Hostage Release
The geopolitical backdrop also provided welcome news for Wall Street. Over the weekend, news broke that Ukranian President Zelensky and Russia’s Putin will meet to negotiate an end to the current conflict. Saturday. India and Pakistan agreed to a ceasefire amid a multi-day skirmish. Meanwhile, the final living Israeli hostage was released by Hamas. Finally, President Trump will make his first international trip of his second presidency when he visits the Middle East on Tuesday.
Bottom Line
An unexpected thaw in US-China trade relations is sending US equity markets soaring this morning.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.